|
Name
|
Title
|
Citizenship
|
Principal Occupation and, if not employed by Gilead Sciences, Inc., Name, Principal Business and Address of Employer
|
|
Daniel P. O’Day
|
Chief Executive Officer, Chairman and Director
|
United States
|
*
|
|
Jacqueline K. Barton, Ph.D.
|
Director
|
United States
|
Professor Emerita, California Institute of Technology
|
|
Jeffrey A. Bluestone, Ph.D.
|
Director
|
United States
|
Former President and Chief Executive Officer, Sonoma Biotherapeutics
|
|
Sandra J. Horning, M.D.
|
Director
|
United States
|
Retired Chief Medical Officer, Roche Inc.
|
|
Kelly A. Kramer
|
Director
|
United States
|
Retired Executive Vice President and Chief Financial Officer, Cisco Systems, Inc.
|
|
Ted W. Love, M.D.
|
Director
|
United States
|
Former Chair of Board of Directors, Biotechnology Innovation Organization
|
|
Harish Manwani
|
Director
|
Singapore
|
Senior Operating Partner, Blackstone
|
|
Javier J. Rodriguez
|
Director
|
Mexico
|
Chief Executive Officer, DaVita, Inc.
|
|
Anthony Welters
|
Director
|
United States
|
Lead Independent Director; Chairman and Chief Executive Officer, CINQ Care
|
|
Andrew D. Dickinson
|
Chief Financial Officer
|
United States
|
*
|
|
Johanna Mercier
|
Chief Commercial & Corporate Affairs Officer
|
United States
|
*
|
|
Dietmar Berger, M.D., Ph.D.
|
Chief Medical Officer
|
United States
|
*
|
|
Keeley Cain Wettan
|
Executive Vice President, General Counsel, Legal & Compliance
|
United States
|
*
|